Page 996 - Veterinary Immunology, 10th Edition
P. 996

macrophages, or M cells and presented to intestinal T cells in such a
  VetBooks.ir  way that they drive the development of IL-10–producing Treg cells.

               Other tolerance-promoting molecules include retinoic acid, IDO,
               and TGFβ. The microbiota appear to play a minor role in oral

               tolerance since it develops in germ-free animals. If this tolerance
               breaks down, a type 2 response triggered by IL-33 and ILCs may
               occur. IL-33 increases mucosal permeability and promotes Th2
               skewing of the immune response. In such cases, class-switching

               results in the production of IgE and the development of food
               allergies. Th2 responses may also occur if Tregs are destroyed or
               dysfunctional.
                  Recent experimental evidence suggests that certain intestinal

               infections may initiate food allergies by breaking oral tolerance.
               Thus reoviruses can trigger Th1 responses in Peyer's patches. The
               type I interferons induced by the infection then suppress pTreg
               activation and so permit food allergens to trigger immune

               responses. This has been demonstrated in the case of Th1 responses
               to gluten but could well apply to Th2 responses as well.
                  About 2% of food protein is absorbed from the intestine as
               peptide fragments large enough to be recognized as foreign. More

               may enter if there are defects in the integrity of the enterocyte tight-
               junction barrier. Antigens may enter the bloodstream and reach
               skin mast cells within a few minutes. It has been estimated that up
               to 30% of skin diseases in dogs are due to allergies and that

               responses to food allergens may account for many cases of
               cutaneous disease in dogs and cats, although their true prevalence
               is unknown. The clinical consequences of food allergies are seen
               both in the digestive tract and on the skin (Fig. 30.4).




























                                                         996
   991   992   993   994   995   996   997   998   999   1000   1001